Surgical approach in oligometastatic non-small cell lung cancer

The vast majority of lung cancer (80%) are non-small cell lung cancer (NSCLC) presenting in huge proportion of patients in a metastatic stage at the time of diagnosis with an overall survival (OS) of only 6 months. Standard treatment at this stage involves systemic platinum based chemotherapy improv...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Transl Med
Glavni autori: Patrini, Davide, Panagiotopoulos, Nikolaos, Bedetti, Benedetta, Mitsos, Sofoklis, Crisci, Roberto, Solli, Piergiorgio, Bertolaccini, Luca, Scarci, Marco
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2018
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890050/
https://ncbi.nlm.nih.gov/pubmed/29666816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.02.16
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items